Onc Now | Episode 10
In this episode of Onc Now, Jonathan is joined by Dave Cescon, a Medical Oncologist and Clinician Scientist at the Princess Margaret Cancer Centre, Toronto, Canada. Together, they explore the transformative impact of CDK4/6 inhibitors, challenges in liquid biopsy research, and the potential of mRNA vaccines in oncology.
Spotify | Apple | Amazon Music | Download MP3 (43 mins)
Dave Cescon, Medical Oncologist and Clinician Scientist at the Princess Margaret Cancer Centre in Toronto, Canada. With a background in biochemistry, oncology, and medical biophysics, Cescon’s work focuses on leveraging tumour analyses to improve breast cancer outcomes. His expertise spans translational research, treatment resistance, and the development of novel therapies.
Timestamps:
(02:44) Swimming in Toronto: competitive versus open water
(08:06) FromiInternal medicine to breast cancer research
(14:09) Translational research and circulating tumour DNA
(19:53) The role of CDK4/6 inhibitors in breast cancer
(29:04) FDA approval of ribociclib for high-risk early breast cancer
(31:45) The future of mRNA vaccines for personalised cancer care
(37:34) Cescon’s research challenges and innovations
(39:13) Three wishes for healthcare
